Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate NMB in Total Hip Replacement (HIPPO)
NCT05562999Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium, sponsored by Radboud University Medical Center. Started Nov 2022; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT05562999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05562999.